Membrane transport of folates
- PMID: 12852262
- DOI: 10.1016/s0083-6729(03)01012-4
Membrane transport of folates
Abstract
The chapter reviews the current understanding of the transport mechanisms for folates in mammalian cells--their molecular identities and organization, tissue expression, regulation, structures, and their kinetic and thermodynamic properties. This encompasses a variety of diverse processes. Best characterized is the reduced folate carrier, a member of the SLC19 family of facilitative carriers. But other facilitative organic anion carriers (SLC21), largely expressed in epithelial tissues, transport folates as well. In addition to these bi-directional carrier systems are the membrane-localized folate receptors alpha and beta, that mediate folate uptake unidirectionally into cells via an endocytotic process. There are also several transporters, typified by the family of multidrug resistance-associated proteins, that unidirectionally export folates from cells. There are transport activities for folates, that function optimally at low pH, related in part to the reduced folate carrier, with at least one activity that is independent of this carrier. The reduced folate carrier-associated low-pH route mediates intestinal folate transport. This review considers how these different transport processes contribute to the generation of transmembrane folate gradients and to vectorial flows of folates across epithelia. The role of folate transporters in mouse development, as assessed by homologous deletion of folate receptors and the reduced folate carrier, is described. Much of the focus is on antifolate cancer chemotherapeutic agents that are often model surrogates for natural folates in transport studies. In particular, antifolate transport mediated by the reduced folate carrier is a major determinant of the activity of, and resistance to, these agents. Finally, many of the key in vitro findings on the properties of antifolate transporters are now beginning to be extended to patient specimens, thus setting the stage for understanding response to these drugs in the clinical setting at the molecular level.
Similar articles
-
Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.J Biol Chem. 1995 Apr 7;270(14):7842-9. doi: 10.1074/jbc.270.14.7842. J Biol Chem. 1995. PMID: 7713875
-
Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates.Semin Oncol. 1999 Apr;26(2 Suppl 6):11-23. Semin Oncol. 1999. PMID: 10598550 Review.
-
Mechanisms of membrane transport of folates into cells and across epithelia.Annu Rev Nutr. 2011 Aug 21;31:177-201. doi: 10.1146/annurev-nutr-072610-145133. Annu Rev Nutr. 2011. PMID: 21568705 Free PMC article. Review.
-
Effects of folate receptor expression following stable transfection into wild type and methotrexate transport-deficient ZR-75-1 human breast cancer cells.J Biol Chem. 1992 Nov 25;267(33):24140-7. J Biol Chem. 1992. PMID: 1429743
-
The mechanism of carrier-mediated transport of folates in BeWo cells: the involvement of heme carrier protein 1 in placental folate transport.Biosci Biotechnol Biochem. 2008 Feb;72(2):329-34. doi: 10.1271/bbb.70347. Epub 2008 Feb 7. Biosci Biotechnol Biochem. 2008. PMID: 18256483
Cited by
-
Influence of Methylenetetrahydrofolate Reductase C677T, A1298C, and G80A Polymorphisms on the Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.Leuk Res Treatment. 2012;2012:292043. doi: 10.1155/2012/292043. Epub 2012 Oct 17. Leuk Res Treatment. 2012. PMID: 23198157 Free PMC article.
-
Surface modification of gold nanoparticles with 6-mercapto-1-hexanol to facilitate dual conjugation of protoporphyrin IX and folic acid for improving the targeted photochemical internalization.Iran J Basic Med Sci. 2022 Aug;25(8):970-979. doi: 10.22038/IJBMS.2022.63622.14033. Iran J Basic Med Sci. 2022. PMID: 36159333 Free PMC article.
-
Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma.Blood Res. 2016 Mar;51(1):50-7. doi: 10.5045/br.2016.51.1.50. Epub 2016 Mar 25. Blood Res. 2016. PMID: 27104192 Free PMC article.
-
Effects of 5' untranslated region diversity on the posttranscriptional regulation of the human reduced folate carrier.Biochim Biophys Acta. 2007 Feb;1769(2):131-8. doi: 10.1016/j.bbaexp.2006.12.006. Epub 2007 Jan 10. Biochim Biophys Acta. 2007. PMID: 17306382 Free PMC article.
-
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.Neuro Oncol. 2009 Feb;11(1):2-8. doi: 10.1215/15228517-2008-082. Epub 2008 Sep 19. Neuro Oncol. 2009. PMID: 18806228 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical